Jon Björnsson appointed new CEO of ORF Genetics and Sif Cosmetics

ORF Genetics announced today that Mr. Jon Björnsson has been appointed new CEO of the company and its subsidiary, Sif Cosmetics.

Read more

ORF Genetics‘ ISOkine growth factors– The Best European Biotechnology Product in 2013

At the European Biotechnology Congress in Bratislava last week, the ISOkine growth factors produced by ORF Genetics were chosen this year’s Best Biotechnology Product in the category of innovative products that solve or tackle important problems in human health. The awards are given in recognition of distinguished contribution to the European Biotechnology Industry, by a small or medium sized European company.

Read more

ORF Genetics to offer endotoxin- and animal-free FGFb and mLIF for stem cell research

ORF Genetics announced today that the company has added endotoxin- and animal-free human Fibroblast Growth Factor Basic (FGF basic) and mouse Leukemia Inhibitory Factor (mouse LIF) to its portfolio of growth factors for stem cell research.

Read more

Founders of ORF Genetics receive recognition from the Association of Chartered Engineers in Iceland

The founders of ORF Genetics were awarded an honorary recognition at the centennial of the Association of Chartered Engineers in Iceland last week.

Read more

ORF Genetics finalizes a share issue

ORF Genetics in cooperation with Arctica Finance has finalized a share issue in the amount of ISK 300 million. Fourteen domestic and foreign investors participated in the share issue which was oversubscribed by 13.7%.

Read more

DM Corporation and ORF Genetics to collaborate on protein drugs

An MOU signed during official visit of Mrs. Preneet Kau, Indian Minister of State for External Affairs, to Iceland.
Aiming for production, marketing and sales of protein drugs on the international market

Read more

Volcanic eruption has no effect on ORF Genetics' operations

We would like to inform you that the volcanic eruption in Eyjafjallajokull glacier in Iceland is not effecting ORF Genetics' operations.

Read more

ORF Genetics moves headquarters to new facilities

ORF Genetics is in the process of moving its headquarters to Víkurhvarf 3, Kópavogur. The company has been based in Keldnaholt in Reykjavík since 2007, but will now move to new and custom-made facilities in Kópavogur.

Read more

Indian Ambassador to Iceland visits ORF Genetics Green Factory

The ambassador of India to Iceland Hon. Mr. S. Swaminathan visited the ORF Genetics Green Factory August 19th.

Read more

TotipotentSC and ORF Genetics sign an agreement for distribution in India.

ORF Genetics and TotipotentSC have signed an agreement for distribution of ORF Genetics ISOkine™ line of biorisk-free growth factors and cytokines in India.

Read more

The President of Iceland visits the Green Factory

President Ólafur Ragnar Grímsson visited the ORF Genetics Green Factory March 5th.

Read more

ORF Genetics Announces Distribution Agreement with Sapphire Biosciences for the distribution of its Biorisk-free ISOKine line of growth factors and cytokines in Australia and New Zealand

Reykjavik, Iceland and Redfern, Australia.

Read more

ORF Genetics at The 54th International Biology Days (JIB) in Paris

ORF Genetics welcomes you to visit us at JIB 2009 at the CNIT - Paris la Defense on November 4-6, booth number A 11.

Read more

Icelandic ORF Genetics opens distribution channel for Italy; signs distribution agreement with Voden Medical

Reykjavik, Iceland and Borromeo, Italy.

Read more

ORF Genetics Enters Distribution Agreement with Cambridge Bioscience for the distribution of its ISOKine line of products in the United Kingdom and Ireland

Reykjavik, Iceland and Cambridge, United Kingdom

Read more

Icelandic ORF Genetics opens distribution channel for Germany, Austria and Switzerland; signs distribution agreement with CellSystems Biotechnologie Vertrieb

Reykjavik, Iceland and St. Katharinen, Germany.

Read more

ORF Genetics Enters Distribution Agreement With Veritas Corp. of Japan for the distribution of its ISOKine line of products

Reykjavik, Iceland and Tokyo, Japan.

Read more

ORF Genetics Announces Distribution Agreement with Bio-Medical Science CO (BMS) Korea for the distribution of its Biorisk-free ISOKine line of growth factors and cytokines

Reykjavik, Iceland and Seoul, Korea.

Read more

HemoGenix, Inc Announces Implementation of ORF Genetics Human Growth Factors and Cytokines in all Human HALO Assay Kits and Contract Research Services

Colorado Springs, CO and Reykjavik, Iceland.

Read more

Singer Björk visits ORF

Recently singer Björk visited ORF Genetics headquarters.

Read more

ORF Genetics Opens Revolutionary “Green Factory” in Iceland - Human growth factors produced in barley grain, using renewable, geothermal energy

Read more

Biorisk-free Growth Factors Now Available to the Cosmeceutical Industry to Meet Growing Demand for Safe Anti-Aging Ingredients

Read more

Icelandic Biotech Company Introduces First-ever Biorisk-free Growth Factors to Global R&D Market

Read more